UNSPSC 51291602: Monometacrine

This classification denotes an antidepressant agent with the molecular formula C19H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 3FDC82890Y chemically known as 9,9-dimethyl-10-(3-(methylamino)propyl)acridan but generally known as monometacrine, which bears US NIH Compound Identifier 145765. European Medicines Agency schedules Monometacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09051MIG.

UNSPSC 51291602 Monometacrine, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities solicited naloxone and safe drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription fulfillment capabilities (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations concern monometacrine specifically, and the code shows a significant mismatch between its nominal scope and what state and local governments are actually buying under this classification.

The issuing bodies represent a mix of county health departments, state health agencies, and regional cooperative purchasing vehicles. Geographic activity spans Florida, Texas, and Minnesota, with the Minnesota procurement reaching multiple states through cooperative purchasing. The most recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (response deadline Jul 26, 2023); Texas HHS Commission's RFI regarding direct-to-manufacturer prescription programs (response deadline Apr 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with proposals due Mar 26, 2026, and contract effectiveness Jul 1, 2026. Given the divergence between the code's stated commodity and the work actually being procured, vendors should verify code assignment before pursuing opportunities tagged under this classification.